States Seek OK Of $400M Sandoz Generic Price-Fixing Deal

By Brian Steele · October 2, 2026, 5:04 PM EDT

A coalition of 43 states and territories is seeking court approval of a $400 million settlement that would resolve allegations Sandoz Inc. and its subsidiary Fougera Pharmaceuticals Inc. participated in a...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

IN RE: GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION

Case Number

2:16-md-02724

Court

Pennsylvania Eastern

Nature of Suit

Other Statutes: Anti-Trust

Date Filed

August 05, 2016

Case Title

Connecticut et al v. Aurobindo Pharma USA, Inc. et al

Case Number

3:16-cv-02056

Court

Connecticut

Nature of Suit

410 Anti-Trust

Date Filed

December 15, 2016

Case Title

Connecticut et al v. Teva Pharmaceuticals USA, Inc.

Case Number

3:19-cv-00710

Court

Connecticut

Nature of Suit

410 Anti-Trust

Date Filed

May 10, 2019

Case Title

Connecticut et al v. Sandoz, Inc. et al

Case Number

3:20-cv-00802

Court

Connecticut

Nature of Suit

410 Anti-Trust

Date Filed

June 10, 2020

Case Title

Connecticut et al v. Novartis AG et al

Case Number

2:26-cv-00160

Court

Connecticut

Nature of Suit

Anti-Trust

Date Filed

February 02, 2026